how i see it
control groups are either standard of care or placebo.
hyaluronic acid is not the current standard of care. it is experimental.
msb is developing a new experimental therapy using cells with HA.
they have done their research and it was found
benefits of cells plus HA, over cells alone in our phase 3 results.
benefit of cells vs HA alone, from phase 2. fda agrees
this article is informative on the potential for msc and other compositions with HA for disc disease![]()
- Forums
- ASX - By Stock
- MSB
- MSB 2022 - The road to commercialisation
MSB
mesoblast limited
Add to My Watchlist
0.91%
!
$1.67

MSB 2022 - The road to commercialisation, page-671
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.67 |
Change
0.015(0.91%) |
Mkt cap ! $2.133B |
Open | High | Low | Value | Volume |
$1.65 | $1.67 | $1.63 | $3.655M | 2.203M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 48000 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 98565 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 48000 | 1.660 |
4 | 12654 | 1.655 |
7 | 107190 | 1.650 |
2 | 16000 | 1.640 |
2 | 49999 | 1.635 |
Price($) | Vol. | No. |
---|---|---|
1.670 | 98565 | 7 |
1.675 | 29112 | 7 |
1.680 | 9000 | 3 |
1.685 | 8000 | 3 |
1.690 | 27206 | 4 |
Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |